Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron up 10% on FDA approval
Marketwatch
Mon, 11/21/11 - 12:59 pm
Tags:
Regeneron, FDA, Eyelea
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Yahoo/PR NewsWire
Sat, 11/19/11 - 11:36 am
Tags:
Regeneron, Eylea, macular degeneration, age-related macular degeneration
Regeneron And Amgen: More Breakthrough Drugs On The Horizon
Seeking Alpha
Fri, 11/18/11 - 11:45 am
Tags:
Amgen, Regeneron, AMG145, PCSK9 inhibitor
New Sanofi/Regeneron Drug Leads To Dramatic Reductions In Bad Cholesterol
Forbes
Thu, 11/10/11 - 01:45 pm
Tags:
Sanofi, Regeneron, RGN727, LDL cholesterol, Lipitor
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
Tags:
FDA, Regeneron, Vertex, Pharmasset, pSivida, Alimera, Salix, Teva Pharmaceuticals, BioSante, Transcept
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Fri, 10/28/11 - 11:07 am
Tags:
Celgene, Pacira, Incyte, BioSante, Regeneron, Transcept, Antares
Regeneron 3Q loss widens as expenses climb
MSNBC
Thu, 10/27/11 - 04:11 pm
Tags:
Regeneron, earnings
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Tags:
Bristol-Myers Squibb, Dapagliflozin, BioSante, Bio-T-Gel, Regeneron, Eylea, Transcept, Intermezzo, Incyte, ruxolitinib, Antares, Anturol
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Tags:
Regeneron, Roche, Avastin, wet-AMD, age-related macular degeneration
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Sat, 09/10/11 - 09:55 am
Tags:
Regeneron, Eylea, age-related macular degeneration
FDA Approval Process Sets Higher Bar For What's Treatable
Seeking Alpha
Thu, 09/8/11 - 11:12 am
Tags:
FDA, AstraZeneca, JNJ, Perrigo Company, Regeneron, generics
Biotech Busts And Breakthroughs For August
Forbes
Thu, 09/1/11 - 11:34 am
Tags:
Mako Surgical, Luminex, Regeneron, Pharmasset, ViroPharma, Dendreon, Pacific Biosciences, ZOLL Medical, Savient, Human Genome Sciences
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Tags:
Regeneron, Sanofi, hypercholesterolemia, PCSK9, Amgen, Merck, Alnylam, Bristol-Myers Squibb, REGN727
Biotech Stocks Pains Continue As Outflows Persist
Forbes
Mon, 08/22/11 - 11:59 am
Tags:
Biomarin, Regeneron, Spectrum
Regeneron: A Poke in the Eye From the FDA
Motley Fool
Fri, 08/19/11 - 09:05 am
Tags:
Regeneron, FDA, Eyelea, macular degeneration
Regeneron Says FDA Delays Eylea Drug for Blindness
Bloomberg
Wed, 08/17/11 - 08:27 am
Tags:
Regeneron, FDA, blindness, Eylea, Lucentis, Roche
The Next Big Thing in Biotech: Regeneron Pharmaceuticals (video)
The Street
Sun, 08/14/11 - 11:27 am
Tags:
Regeneron
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
Tags:
biotech, drug approvals, FDA, Eyelea, Regeneron, Dendreon, Provenge, NuPathe, Zelrix, Adcetris, Seattle Genetics, Soliris, Alexion, Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, EXPAREL, Pacira, Roche, Zelboraf, Iluvien, Alimera, Bio-T-Gel, Teva Pharmaceuticals, BioSante, Zevalin, Spectrum, ruxolitinib, Incyte, Novartis, Pfizer, crizotinib, Antares, Anturol, Bydureon, Amlyin, Eli Lilly, Alkermes, AZ-004, Alexza, Corlux, Corcept Therapeutics, Affymax, Takeda, peginesatide, Levadex, MAP Pharmaceuticals
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thu, 08/4/11 - 10:57 am
Tags:
Dendreon, Provenge, InterMune, Human Genome Sciences, Seattle Genetics, Regeneron, Savient
Biotech Calendar: Key Dates for August
TheStreet.com
Tue, 08/2/11 - 12:29 pm
Tags:
Alexa, Gilead Sciences, Regeneron, Dendreon, NuPathe, Provenge, Adcetris, Seattle Genetics, Eyelea, Btripla, Zelrix, AZ-004

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.